
Microport Cardioflow Medtech Corp
HKEX:2160

Microport Cardioflow Medtech Corp
Non-Reccuring Items
Microport Cardioflow Medtech Corp
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Microport Cardioflow Medtech Corp
HKEX:2160
|
Non-Reccuring Items
ÂĄ81.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Non-Reccuring Items
ÂĄ8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Non-Reccuring Items
ÂĄ17.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Non-Reccuring Items
ÂĄ6.1m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Non-Reccuring Items
ÂĄ9.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Non-Reccuring Items
ÂĄ13.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Microport Cardioflow Medtech Corp
Glance View
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.

See Also
What is Microport Cardioflow Medtech Corp's Non-Reccuring Items?
Non-Reccuring Items
81.3m
CNY
Based on the financial report for Dec 31, 2024, Microport Cardioflow Medtech Corp's Non-Reccuring Items amounts to 81.3m CNY.